Federal Judge Recommends $68 Million Award to Gilead in Counterfeit HIV Drug Case
In a significant development, a New York federal magistrate judge has recommended that biopharmaceutical company Gilead Sciences Inc. be awarded $68 million. This ruling comes in the wake of allegations that a group of entities produced counterfeit HIV drugs. These companies, according to the court documents, failed to respond to the allegations, leading to the…